Senseonics (SENS) Competitors $0.49 +0.00 (+0.78%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.49 +0.00 (+0.45%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SENS vs. TRNS, EYPT, ALNT, AEHR, LAB, CTKB, QSI, QTRX, FEIM, and MASSShould you be buying Senseonics stock or one of its competitors? The main competitors of Senseonics include Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Standard BioTools (LAB), Cytek Biosciences (CTKB), Quantum-Si (QSI), Quanterix (QTRX), Frequency Electronics (FEIM), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Senseonics vs. Its Competitors Transcat Eyepoint Pharmaceuticals Allient Aehr Test Systems Standard BioTools Cytek Biosciences Quantum-Si Quanterix Frequency Electronics 908 Devices Senseonics (NYSE:SENS) and Transcat (NASDAQ:TRNS) are both small-cap measuring and control equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Which has stronger valuation and earnings, SENS or TRNS? Transcat has higher revenue and earnings than Senseonics. Senseonics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSenseonics$23.68M13.50-$60.39M-$0.11-4.44Transcat$278.42M2.50$14.52M$1.5647.79 Do insiders and institutionals have more ownership in SENS or TRNS? 12.4% of Senseonics shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 4.3% of Senseonics shares are owned by insiders. Comparatively, 2.8% of Transcat shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media refer more to SENS or TRNS? In the previous week, Transcat had 5 more articles in the media than Senseonics. MarketBeat recorded 5 mentions for Transcat and 0 mentions for Senseonics. Transcat's average media sentiment score of 0.59 beat Senseonics' score of 0.00 indicating that Transcat is being referred to more favorably in the news media. Company Overall Sentiment Senseonics Neutral Transcat Positive Do analysts prefer SENS or TRNS? Senseonics currently has a consensus target price of $1.55, indicating a potential upside of 217.10%. Transcat has a consensus target price of $112.20, indicating a potential upside of 50.50%. Given Senseonics' stronger consensus rating and higher possible upside, analysts plainly believe Senseonics is more favorable than Transcat.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Senseonics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50Transcat 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has more volatility and risk, SENS or TRNS? Senseonics has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Transcat has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Is SENS or TRNS more profitable? Transcat has a net margin of 5.21% compared to Senseonics' net margin of -362.30%. Transcat's return on equity of 6.47% beat Senseonics' return on equity.Company Net Margins Return on Equity Return on Assets Senseonics-362.30% -842.25% -67.99% Transcat 5.21%6.47%5.02% SummaryTranscat beats Senseonics on 11 of the 17 factors compared between the two stocks. Get Senseonics News Delivered to You Automatically Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SENS vs. The Competition Export to ExcelMetricSenseonicsProcess control instruments IndustryMedical SectorNYSE ExchangeMarket Cap$319.78M$19.83B$5.49B$20.63BDividend YieldN/A0.60%4.73%3.67%P/E Ratio-3.7618.9028.8329.01Price / Sales13.507.10372.0766.10Price / CashN/A22.2635.4522.82Price / Book6.985.038.274.43Net Income-$60.39M$495.21M$3.25B$993.74M7 Day Performance-11.53%-7.62%-3.73%-3.39%1 Month Performance-0.24%-2.24%4.29%-2.10%1 Year Performance25.30%13.22%25.87%10.09% Senseonics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SENSSenseonics1.6234 of 5 stars$0.49+0.8%$1.55+217.1%+21.1%$319.78M$23.68M-3.7690TRNSTranscat3.3122 of 5 stars$82.71-1.7%$112.20+35.7%-32.9%$770.69M$278.42M53.021,245Upcoming EarningsEYPTEyepoint Pharmaceuticals1.91 of 5 stars$10.03-4.3%$25.67+155.9%+6.4%$690.16M$43.27M-4.16120News CoverageUpcoming EarningsALNTAllient2.3064 of 5 stars$39.91+0.4%$31.00-22.3%+38.5%$675.68M$529.97M67.652,525News CoveragePositive NewsUpcoming EarningsGap DownAEHRAehr Test Systems1.6485 of 5 stars$20.91-3.8%N/A+1.8%$622.51M$58.97M-160.8390Gap DownLABStandard BioTools3.3857 of 5 stars$1.42+1.4%$2.50+76.1%-8.5%$539.34M$174.43M-4.06620News CoveragePositive NewsGap DownCTKBCytek Biosciences2.344 of 5 stars$3.75+1.6%$5.60+49.3%-43.2%$474.98M$200.45M-41.66500Positive NewsUpcoming EarningsQSIQuantum-Si2.5321 of 5 stars$1.79-7.3%$3.48+94.1%+47.6%$328.47M$3.06M-2.63150Upcoming EarningsGap DownQTRXQuanterix2.2462 of 5 stars$6.49+10.9%$13.50+108.0%-58.3%$324.20M$133.92M-4.99460Upcoming EarningsGap DownFEIMFrequency Electronics1.0606 of 5 stars$27.87-0.4%N/A+99.3%$271.12M$69.81M11.28200Short Interest ↑Gap DownHigh Trading VolumeMASS908 Devices2.0947 of 5 stars$7.33-1.2%$5.33-27.2%+26.4%$262.85M$59.63M-13.5760Positive NewsUpcoming EarningsAnalyst ForecastGap Down Related Companies and Tools Related Companies TRNS Alternatives EYPT Alternatives ALNT Alternatives AEHR Alternatives LAB Alternatives CTKB Alternatives QSI Alternatives QTRX Alternatives FEIM Alternatives MASS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SENS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senseonics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senseonics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SENS Stock Alerts